MPCG
TECH icon

Matrix Private Capital Group’s Bio-Techne TECH Stock Holding History

Matrix Private Capital Group’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,312
Closed -$200K – 243
2022
Q2 		$200K Sell
2,312
-12
-0.5% -$1.13K 0.11% 157
2022
Q1 		$251K Buy
2,324
+12
+0.5% +$1.24K 0.12% 149
2021
Q4 		$299K Sell
2,312
-4
-0.2% -$490 0.14% 134
2021
Q3 		$280K Sell
2,316
-532
-19% -$64.7K 0.15% 136
2021
Q2 		$321K Hold
2,848
– – 0.18% 120
2021
Q1 		$272K Sell
2,848
-60
-2% -$5.47K 0.16% 139
2020
Q4 		$231K Buy
+2,908
New +$211K 0.17% 135

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Matrix Private Capital Group's TECH Position: Q3 2022 in Review

Matrix Private Capital Group sold out of Bio-Techne (TECH) in Q3 2022, closing a stake of 2,312 shares — an estimated $200K sold.

Matrix Private Capital Group first reported a position in TECH in Q4 2020 and held it in 7 quarters. The position peaked at $321K in Q2 2021. 536 funds tracked by Wall St. Rank hold TECH as of Q3 2022.

  • Matrix Private Capital Group reported no remaining Bio-Techne position as of Q3 2022 after selling out during the quarter.
  • Matrix Private Capital Group sold 2,312 Bio-Techne shares in Q3 2022, an estimated $200K.
  • Matrix Private Capital Group first reported a position in Bio-Techne in Q4 2020 and held it in 7 quarters.
  • Matrix Private Capital Group's Bio-Techne position peaked at $321K in Q2 2021.
  • 536 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2022.

Based on Matrix Private Capital Group's 13F filing for Q3 2022, filed 14 Nov 2022.